Anika Therapeutics (ANIK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 55,629 | 62,368 | 62,822 | 68,629 | 68,740 |
| Receivables | 23,594 | 28,357 | 33,773 | 32,077 | 26,360 |
| Inventories | 23,809 | 39,629 | 51,464 | 49,408 | 24,428 |
| Other current assets | 5,126 | 0 | 0 | 0 | 36,305 |
| TOTAL | $113,652 | $136,106 | $155,000 | $158,962 | $163,309 |
| Non-Current Assets | |||||
| PPE Net | 38,994 | 44,572 | 47,685 | 46,057 | 37,445 |
| Intangibles | 9,615 | 10,737 | 11,319 | 11,700 | 10,147 |
| Other Non-Current Assets | 40,479 | 39,990 | 48,651 | 47,025 | 59,731 |
| TOTAL | $89,088 | $95,299 | $107,655 | $104,782 | $107,323 |
| Total Assets | $202,740 | $231,405 | $262,655 | $263,744 | $270,632 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 5,617 | 6,805 | 9,994 | 10,022 | 6,194 |
| Accrued Expenses | 13,567 | 18,688 | 16,127 | 18,438 | 14,066 |
| Other current liabilities | 4,122 | N/A | N/A | N/A | 10,799 |
| TOTAL | $23,306 | $25,493 | $26,121 | $28,460 | $31,059 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 25,445 | 26,048 | 26,196 | 26,748 | 27,308 |
| TOTAL | $25,445 | $26,048 | $26,196 | $26,748 | $27,308 |
| Total Liabilities | $48,751 | $51,541 | $52,317 | $55,208 | $58,367 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 14,176 | 14,646 | 14,797 | 14,828 | 14,850 |
| Common Shares | 144 | 147 | 148 | 148 | 147 |
| Retained earnings | 71,667 | 93,532 | 123,450 | 123,538 | 128,052 |
| Other shareholders' equity | -6,783 | -5,701 | -6,416 | -6,315 | -5,943 |
| TOTAL | $153,989 | $179,864 | $210,338 | $208,536 | $212,265 |
| Total Liabilities And Equity | $202,740 | $231,405 | $262,655 | $263,744 | $270,632 |